Physician profile
Jill R Schofield
NPI 1972630531
$10,094.87
in general payments reported to CMS, 2019-2025
7 companies · $1,270 in 2025
The $1,270 reported for 2025 was more than what 88% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,576 · 2022: $15.11 · 2023: $7,234 · 2025: $1,270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $6,000 · Consulting Fee: $1,270 · Travel and Lodging: $885 · Food and Beverage: $279 · Education: $70.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $6,000.00 |
| Consulting Fee | $1,270.00 |
| Travel and Lodging | $885.22 |
| Food and Beverage | $278.57 |
| Education | $70.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Octapharma USA, INC. | $7,095.92 | 2023 | Panzyga |
| Inova Diagnostics, INC. | $1,500.00 | 2019 | |
| Tersera Therapeutics LLC | $1,285.11 | 2022-2025 | Quzyttir |
| Boston Scientific Corporation | $137.87 | 2023 | |
| Bio Products Laboratory USA, INC. | $38.16 | 2019 | |
| Novartis Pharmaceuticals Corporation | $22.52 | 2019 | |
| Janssen Biotech, INC. | $15.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Schofield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.